uce
ProgressImage ProgressImage
Syngene International Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 539268 border-img ISIN Demat INE398R01022 border-img Book Value 104.14 border-img NSE Symbol SYNGENE border-img Div & Yield % 1.82 border-img Market Cap ( Cr.) 27670.39 border-img P/E 58.16 border-img EPS 11.82 border-img Face Value 10
Quarters
ParticularsMar 2024
()
Dec 2023
()
Sep 2023
()
Gross Sales864.70791.90830.70
Other Operating Income0.000.000.00
Other Income 15.3028.8021.00
Total Income880.00820.70851.70
Total Expenditure 565.40596.10621.50
PBIDT314.60224.60230.20
Interest 8.506.308.60
PBDT306.10218.30221.60
Depreciation95.7093.6090.90
Tax41.5019.1022.80
Fringe Benefit Tax0.000.000.00
Deferred Tax-20.905.806.30
Reported Profit After Tax189.8099.80101.60
Extra-ordinary Items 0.00-2.96-5.75
Adjusted Profit After Extra-ordinary item189.80102.76107.35
    
EPS (Unit Curr.)4.732.492.53
EPS (Adj) (Unit Curr.)4.732.492.53
Calculated EPS (Unit Curr.)4.722.482.53
Calculated EPS (Adj) (Unit Curr.)4.722.482.53
Calculated EPS (Ann.) (Unit Curr.)18.899.9310.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)18.899.9310.11
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity402.00402.00402.00
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)36.3828.3627.71
PBDTM(%)35.4027.5726.68
PATM(%)21.9512.6012.23
x
x
×
Let's Chat
close
refresh